HER2-targeted therapy in breast cancer: a systematic review of neoadjuvant trials

S Dent, B Oyan, A Honig, M Mano, S Howell - Cancer treatment reviews, 2013 - Elsevier
Targeting human epidermal growth factor receptor 2 (HER2) during or in sequence with
chemotherapy improves overall survival in metastatic and early HER2-overexpressing …
被引用次数：133 相关文章

HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials

S Dent, B Oyan, A Honig… - Cancer Treatment …, 2013 - cancertreatmentreviews.com
Targeting human epidermal growth factor receptor 2 (HER2) during or in sequence with
chemotherapy improves overall survival in metastatic and early HER2-overexpressing …

HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials

S Dent, B Oyan, A Honig… - Cancer Treatment …, 2013 - research.manchester.ac.uk
Targeting human epidermal growth factor receptor 2 (HER2) during or in sequence with
chemotherapy improves overall survival in metastatic and early HER2-overexpressing …

[引用][C] HER2-TARGETED THERAPY IN BREAST CANCER: A SYSTEMATIC REVIEW OF NEOADJUVANT TRIALS

S DENT, B OYAN, A HONIG - 2013 - sid.ir

HER2-targeted therapy in breast cancer: a systematic review of neoadjuvant trials.

S Dent, B Oyan, A Honig, M Mano… - Cancer Treatment …, 2013 - europepmc.org
Targeting human epidermal growth factor receptor 2 (HER2) during or in sequence with
chemotherapy improves overall survival in metastatic and early HER2-overexpressing …

[引用][C] HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials

S Dent, B Oyan, A Honig, M Mano… - Cancer Treatment …, 2013 - repositorio.usp.br
ReP USP - Detalhe do registro: HER2-targeted therapy in breast cancer: A systematic review of
neoadjuvant trials Home About USP Schools USP Schools Escola de Artes, Ciências e …
[PDF] academia.edu

[PDF][PDF] HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials

S Dent, B Oyan, A Honig, M Mano… - Cancer Treatment …, 2013 - academia.edu
abstract Targeting human epidermal growth factor receptor 2 (HER2) during or in sequence
with chemotherapy improves overall survival in metastatic and early HER2-overexpressing …

HER2-targeted therapy in breast cancer: a systematic review of neoadjuvant trials.

S Dent, B Oyan, A Honig, M Mano, SJ Howell - 2013 - christie.openrepository.com
Targeting human epidermal growth factor receptor 2 (HER2) during or in sequence with
chemotherapy improves overall survival in metastatic and early HER2-overexpressing …

[引用][C] HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials

S Dent, B Oyan, A Honig, M Mano… - Cancer Treatment Reviews, 2013 - cir.nii.ac.jp
HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials

S Dent, B Oyan, A Honig, M Mano, S Howell - Cancer Treatment Reviews, 2013 - infona.pl
Targeting human epidermal growth factor receptor 2 (HER2) during or in sequence with
chemotherapy improves overall survival in metastatic and early HER2-overexpressing …